Our top pick for
Beginners

Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.
Updated
ASOS Plc is an internet retail business based in the US. ASOS shares (ASOMY) are listed on the PINK and all prices are listed in US Dollars. ASOS employs 3,824 staff and has a market cap (total outstanding shares value) of USD$7.9 billion.
Our top pick for
Beginners
Our top pick for
Building a portfolio
Our top pick for
Advanced investors
52-week range | USD$12.5 - USD$81.65 |
---|---|
50-day moving average | USD$71.1465 |
200-day moving average | USD$65.2666 |
Wall St. target price | N/A |
PE ratio | 60.8889 |
Dividend yield | N/A (0%) |
Earnings per share (TTM) | USD$1.296 |
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
Valuing ASOS stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of ASOS's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
ASOS's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 61x. In other words, ASOS shares trade at around 61x recent earnings.
ASOS's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 0.8326. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.
The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into ASOS's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.
Gross profit TTM | USD$1.5 billion |
---|---|
Return on assets TTM | 5.84% |
Return on equity TTM | 17.93% |
Profit margin | 3.47% |
Book value | $6.96 |
Market capitalisation | USD$7.9 billion |
TTM: trailing 12 months
We're not expecting ASOS to pay a dividend over the next 12 months.
Over the last 12 months, ASOS's shares have ranged in value from as little as $12.5 up to $81.65. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (PINK average) beta is 1, while ASOS's is 2.5957. This would suggest that ASOS's shares are significantly more volatile than the average for this exchange and represent a higher risk.
ASOS Plc operates as an online fashion retailer in the United Kingdom, the United States, Australia, France, Germany, Spain, Italy, Sweden, the Netherlands, Denmark, Poland, and Russia. It offers womenswear and menswear products. The company sells approximately 85,000 products under the ASOS Design, ASOS Edition, ASOS 4505, and Collusion brands, a well as other global and local third-party brands products primarily through its website, asos.com, as well as through social media platforms. It is also involved in marketing staff employment and payment processing businesses. The company was founded in 2000 and is headquartered in London, the United Kingdom.
Everything we know about the Achilles Therapeutics plc IPO, plus information on how to buy in.
Everything we know about the SEMrush Holdings Inc IPO, plus information on how to buy in.
Everything we know about the ChargePoint IPO, plus information on how to buy in.
Everything we know about the Kaltura Inc IPO, plus information on how to buy in.
Everything we know about the Rocket Lab IPO, plus information on how to buy in.
Everything we know about the Soho House IPO, plus information on how to buy in.
Everything we know about the VIZIO IPO, plus information on how to buy in.
Everything we know about the IDW Media Holdings Inc IPO, plus information on how to buy in.
Everything we know about the Karooooo Ltd IPO, plus information on how to buy in.
Everything we know about the Connect Biopharma Holdings Limited IPO, plus information on how to buy in.